Enter your login e-mail to the account
Search
Search parameters
Search results
- Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles )
- Gilbert‘s syndrome – a disease, risk factor, but also an evolutionary advantage?
MUDr. Iveta Čierna, PhD., RNDr. Katarína Hlinková, MUDr. Gabriela Nagyová, Mgr. Michaela Čižmárová, Mgr. Slavka Požgayová
(3/2015, Review articles )
- Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Personalised medicine and cancer of unknown primary
RNDr. Gabriel Minárik, PhD.
(4/2013, Main topic ) - Nilotinib – inhibítor tyrozínkinázy na liečbu chronickej myelocytovej leukémie (CML)
doc. PharmDr. Juraj Sýkora, CSc.
(2/2009, Drugs & drug classes ) - Genetic perspectives in prediction of cytostatic toxicity
prof. MUDr. László Kovács, DrSc., MPH, MUDr. Sabína Šufliarska, MUDr. Alica Dzurenková, doc. MUDr. Beáta Mladosievičová, CSc., RNDr. Gabriel Minárik, PhD.
(4/2009, Review articles ) - Molecular pathology of selected types of ovarian cancer
doc. MUDr. Karol Kajo, PhD.
(5/2014, Main topic )
- Pharmacogenetics in practice of a clinical pharmacologist and a pharmacist
MUDr. Olga Bartošová, Ph.D., Prof. MUDr. Ondřej Slanař, Ph.D., PharmDr. Irena Netíková, Ph.D.
(3/2016, Clinical pharmacy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy ) - Nové liečivá v EÚ registrované v roku 2014 (I.)
Mgr. Zuzana Šestáková, PharrmDr. Peter Stanko
(1/2015, New drugs )